Equip Rotavirus
Active substance
ATC code
Species
Horses (pregnant mares).
Indications
For vaccination of pregnant mares to provide passive transfer of antibodies to foals to reduce the risk of diarrhoea caused by equine rotavirus type G3P12.
Mares are able to transfer the passive immunity to the foals 4 weeks after the third vaccination. Foals of the vaccinated mares show an increase in antibodies against equine rotavirus for approximately sixty days.
Dose to be administered and administration route
Intramuscular use.
1 ml dose per mare to be administered by deep intramuscular injection.
Vaccination schedule:
Pregnant mares should be given three doses of vaccine consisting of a single 1 ml dose administered at the 8th, 9th and 10th month of each pregnancy.
Adverse reactions
Horses (pregnant mares):
|
Very common (>1 animal / 10 animals treated): |
Elevated temperature[1] |
|
Common (1 to 10 animals / 100 animals treated): |
Injection site pain[2], Injection site swelling3 |
1A transient increase (up to 1.8 °C) in rectal temperature which may last up to 2 days.
2At the swelling site. May last 1-2 days.
3A small visible soft to firm swelling (2.5 ≤ x ≤ 3.5 cm) lasting generally for only 2 days. In most cases these small and transient injection site reactions resolve with no need for treatment.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
